Introduction Lung cancer (LC) remains a disease with poor prognosis despite recent
advances in treatments. Here, we aimed at summarizing the current scientific evidence on …

Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined.
Nevertheless, population‐based lung cancer screening is still not considered standard …

Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States, in large part because of the results of the National Lung Screening Trial …

Lung cancer is the second most common cancer in men and women in the United States;
however, it remains the leading cause of cancer-related death in the United States and …

Randomized-controlled trials have confirmed substantial reductions in lung cancer mortality
with low-dose computed tomography (LDCT) screening. Evidence on how to integrate …

Lung cancer continues to be one of the main causes of cancer death in Europe. Low-dose
computed tomography (LDCT) has shown high potential for screening of lung cancer in …

Several trials have shown that low-dose computed tomography-based lung cancer
screening (LCS) allows a substantial reduction in lung cancer-related mortality, carrying the …

The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes
mortality in 55–69 years-aged smokers and ex-smokers who were randomized to four …

Overdiagnosis is a major potential harm of lung cancer screening; knowing its potential
magnitude helps to optimize screening eligibility criteria. The German Lung Screening …

Background Screening for lung cancer with low radiation dose computed tomography
(LDCT) has a strong evidence base. The European Council adopted a recommendation in …